| 1 | Autophagy Blockage Up-Regulates HLA-Class-I Molecule Expression in Lung Cancer and Enhances Anti-PD-L1 Immunotherapy Efficacy | 4.0 | 1 | Citations (PDF) |
| 2 | Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease Virus | 4.0 | 2 | Citations (PDF) |
| 3 | 75th anniversary of the British Journal of Cancer | 5.7 | 0 | Citations (PDF) |
| 4 | Is it still worth pursuing the repurposing of metformin as a cancer therapeutic? | 5.7 | 60 | Citations (PDF) |
| 5 | Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model | 4.0 | 2 | Citations (PDF) |
| 6 | GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner | 0.6 | 3 | Citations (PDF) |
| 7 | Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities | 5.7 | 12 | Citations (PDF) |
| 8 | A Rab6 to Rab11 transition is required for dense-core granule and exosome biogenesis in Drosophila secondary cells | 3.3 | 2 | Citations (PDF) |
| 9 | Investigations on Zinc Isotope Fractionation in Breast Cancer Tissue Using in vitro Cell Culture Uptake-Efflux Experiments | 2.7 | 7 | Citations (PDF) |
| 10 | Novel humanized monoclonal antibodies for targeting hypoxic human tumors via two distinct extracellular domains of carbonic anhydrase IX | 4.8 | 12 | Citations (PDF) |
| 11 | Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions | 6.4 | 36 | Citations (PDF) |
| 12 | Targeting hypoxia regulated sodium driven bicarbonate transporters reduces triple negative breast cancer metastasis | 7.2 | 13 | Citations (PDF) |
| 13 | Role of Hypoxia in the Interferon Response | 5.0 | 8 | Citations (PDF) |
| 14 | Abstract 5813: Glycogen synthesis as potential novel target in triple negative breast cancer: Glycogen synthase 1 expression in human breast cancers and the impact of downregulation on proliferation of preclinical models | 0.6 | 1 | Citations (PDF) |
| 15 | Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation | 8.5 | 13 | Citations (PDF) |
| 16 | Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast | 4.0 | 3 | Citations (PDF) |
| 17 | Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia Sensor | 4.8 | 1 | Citations (PDF) |
| 18 | Dissecting the heritable risk of breast cancer: From statistical methods to susceptibility genes | 14.2 | 12 | Citations (PDF) |
| 19 | Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancer | 4.5 | 34 | Citations (PDF) |
| 20 | Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast | 5.7 | 11 | Citations (PDF) |
| 21 | Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer | 6.4 | 53 | Citations (PDF) |
| 22 | The Landscape of the Heritable Cancer Genome | 0.6 | 15 | Citations (PDF) |
| 23 | Elevated expression of the adhesion GPCR ADGRL4/ELTD1 promotes endothelial sprouting angiogenesis without activating canonical GPCR signalling | 3.7 | 14 | Citations (PDF) |
| 24 | Unveiling Cancer Metabolism through Spontaneous and Coherent Raman Spectroscopy and Stable Isotope Probing | 4.0 | 50 | Citations (PDF) |
| 25 | Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation | 11.5 | 18 | Citations (PDF) |
| 26 | Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells | 5.5 | 4 | Citations (PDF) |
| 27 | Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer | 5.7 | 12 | Citations (PDF) |
| 28 | Machine learning to guide the use of adjuvant therapies for breast cancer | 17.4 | 30 | Citations (PDF) |
| 29 | Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs | 3.0 | 4 | Citations (PDF) |
| 30 | The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer | 4.8 | 22 | Citations (PDF) |
| 31 | ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression | 2.9 | 5 | Citations (PDF) |
| 32 | Expression and functions of long non-coding RNA NEAT1 and isoforms in breast cancer | 5.7 | 37 | Citations (PDF) |
| 33 | ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype | 4.5 | 8 | Citations (PDF) |
| 34 | Hypoxia Regulates Endogenous Double-Stranded RNA Production via Reduced Mitochondrial DNA Transcription | 2.7 | 16 | Citations (PDF) |
| 35 | Characterising 18F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging | 5.7 | 4 | Citations (PDF) |
| 36 | Partial Breast Reconstruction with Lateral Chest Wall Perforator Flap to Facilitate Breast Conservation in Breast Cancer: First 100 Cases with Cancer Outcomes at 8 Years Follow-Up and the Lessons Learned | 1.9 | 8 | Citations (PDF) |
| 37 | The onset of circulation triggers a metabolic switch required for endothelial to hematopoietic transition | 6.4 | 18 | Citations (PDF) |
| 38 | Comprehensive Imaging Characterization of Colorectal Liver Metastases | 2.7 | 9 | Citations (PDF) |
| 39 | Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin | 5.7 | 33 | Citations (PDF) |
| 40 | Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells | 4.8 | 11 | Citations (PDF) |
| 41 | The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer | 2.5 | 21 | Citations (PDF) |
| 42 | Hypoxia Induces Transcriptional and Translational Downregulation of the Type I IFN Pathway in Multiple Cancer Cell Types | 0.6 | 55 | Citations (PDF) |
| 43 | Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion | 5.7 | 20 | Citations (PDF) |
| 44 | RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain | 7.4 | 20 | Citations (PDF) |
| 45 | COVID-19 and cancer research | 5.7 | 17 | Citations (PDF) |
| 46 | Role of gene signatures combined with pathology in classification of oropharynx head and neck cancer | 3.7 | 11 | Citations (PDF) |
| 47 | Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltration | 5.7 | 28 | Citations (PDF) |
| 48 | Clinical strategies to inhibit tumor vascularization 2020, , 147-176 | | 1 | Citations (PDF) |
| 49 | Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer | 5.7 | 74 | Citations (PDF) |
| 50 | Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: Comparison with histological subregions and impact on pharmacokinetic parameter analysis | 3.1 | 6 | Citations (PDF) |
| 51 | HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer | 9.1 | 224 | Citations (PDF) |
| 52 | Glutamine deprivation alters the origin and function of cancer cell exosomes | 7.4 | 77 | Citations (PDF) |
| 53 | ADGRL4/ELTD1 is a highly conserved angiogenesis-associated orphan adhesion GPCR that emerged with the first vertebrates and comprises 3 evolutionary variants | 3.4 | 10 | Citations (PDF) |
| 54 | BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors | 14.1 | 134 | Citations (PDF) |
| 55 | Landscape of transcriptomic interactions between breast cancer and its microenvironment | 14.1 | 16 | Citations (PDF) |
| 56 | Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis | 2.5 | 40 | Citations (PDF) |
| 57 | Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer Therapy | 1.7 | 32 | Citations (PDF) |
| 58 | FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma | 1.4 | 19 | Citations (PDF) |
| 59 | Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer | 7.7 | 95 | Citations (PDF) |
| 60 | Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism | 2.9 | 20 | Citations (PDF) |
| 61 | ATF4, Hypoxia and Treatment Resistance in Cancer | 0.0 | 2 | Citations (PDF) |
| 62 | ADGRL4/ELTD1 Silencing in Endothelial Cells Induces ACLY and SLC25A1 and Alters the Cellular Metabolic Profile | 3.5 | 17 | Citations (PDF) |
| 63 | 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers | 1.7 | 17 | Citations (PDF) |
| 64 | Endogenous miRNA sponges mediate the generation of oscillatory dynamics for a non-coding RNA network | 1.8 | 4 | Citations (PDF) |
| 65 | High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer | 5.7 | 26 | Citations (PDF) |
| 66 | Development of cancer metabolism as a therapeutic target: new pathways, patient studies, stratification and combination therapy | 5.7 | 27 | Citations (PDF) |
| 67 | Non-angiogenic tumours and their influence on cancer biology | 24.2 | 117 | Citations (PDF) |
| 68 | Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing | 1.4 | 15 | Citations (PDF) |
| 69 | A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424 | 5.7 | 10 | Citations (PDF) |
| 70 | SMER28 is a mTOR-independent small molecule enhancer of autophagy that protects mouse bone marrow and liver against radiotherapy | 2.6 | 12 | Citations (PDF) |
| 71 | miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense | 0.6 | 104 | Citations (PDF) |
| 72 | Advances in Hypoxia-Inducible Factor Biology | 26.3 | 620 | Citations (PDF) |
| 73 | Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors | 14.1 | 100 | Citations (PDF) |
| 74 | Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo | 5.7 | 93 | Citations (PDF) |
| 75 | Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer | 26.3 | 97 | Citations (PDF) |
| 76 | Consensus guidelines for the use and interpretation of angiogenesis assays | 7.4 | 445 | Citations (PDF) |
| 77 | The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells | 7.7 | 45 | Citations (PDF) |
| 78 | Functional Parameters Derived from Magnetic Resonance Imaging Reflect Vascular Morphology in Preclinical Tumors and in Human Liver Metastases | 6.4 | 13 | Citations (PDF) |
| 79 | Hypoxia and Hormone-Mediated Pathways Converge at the Histone Demethylase KDM4B in Cancer | 4.5 | 21 | Citations (PDF) |
| 80 | A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis | 3.6 | 36 | Citations (PDF) |
| 81 | RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition | 2.5 | 23 | Citations (PDF) |
| 82 | miR-193a-3p interaction with HMGB1 downregulates human endothelial cell proliferation and migration | 3.7 | 35 | Citations (PDF) |
| 83 | A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1 | 4.8 | 168 | Citations (PDF) |
| 84 | A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients | 6.4 | 95 | Citations (PDF) |
| 85 | In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer | 29.8 | 23 | Citations (PDF) |
| 86 | Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab | 2.7 | 2 | Citations (PDF) |
| 87 | Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients | 2.1 | 6 | Citations (PDF) |
| 88 | Single-cell heterogeneity in ductal carcinoma in situ of breast | 5.0 | 40 | Citations (PDF) |
| 89 | Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth | 1.7 | 34 | Citations (PDF) |
| 90 | Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation | 1.7 | 65 | Citations (PDF) |
| 91 | Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer | 1.7 | 9 | Citations (PDF) |
| 92 | Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia | 8.4 | 71 | Citations (PDF) |
| 93 | Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM) | 1.3 | 23 | Citations (PDF) |
| 94 | Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor Growth | 0.6 | 79 | Citations (PDF) |
| 95 | Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot | 26.3 | 206 | Citations (PDF) |
| 96 | Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study | 0.2 | 13 | Citations (PDF) |
| 97 | Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic Treatment | 10.0 | 28 | Citations (PDF) |
| 98 | The Role of pH Regulation in Cancer Progression | 0.0 | 12 | Citations (PDF) |
| 99 | Imaging oligometastatic cancer before local treatment | 21.9 | 19 | Citations (PDF) |
| 100 | MEF2 transcription factors are key regulators of sprouting angiogenesis | 4.8 | 63 | Citations (PDF) |
| 101 | Normal tissue radioprotection by amifostine via Warburg-type effects | 3.7 | 29 | Citations (PDF) |
| 102 | Why some tumours trigger neovascularisation and others don’t: the story thus far | 2.3 | 15 | Citations (PDF) |
| 103 | Methods: Using Three-Dimensional Culture (Spheroids) as an In Vitro Model of Tumour Hypoxia | 0.0 | 50 | Citations (PDF) |
| 104 | Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy | 3.6 | 180 | Citations (PDF) |
| 105 | Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers | 3.0 | 46 | Citations (PDF) |
| 106 | Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments | 4.8 | 190 | Citations (PDF) |
| 107 | The tumour hypoxia induced non-coding transcriptome | 9.3 | 99 | Citations (PDF) |
| 108 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | 13.8 | 4,327 | Citations (PDF) |
| 109 | Antiangiogenic therapy in oncology: current status and future directions | 35.3 | 659 | Citations (PDF) |
| 110 | Imaging biomarker roadmap for cancer studies | 25.3 | 831 | Citations (PDF) |
| 111 | The Role of Oxygen in Avascular Tumor Growth | 2.5 | 48 | Citations (PDF) |
| 112 | Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect | 1.7 | 22 | Citations (PDF) |
| 113 | O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer | 1.7 | 39 | Citations (PDF) |
| 114 | Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth | 1.7 | 16 | Citations (PDF) |
| 115 | Does Amifostine Reduce Metabolic Rate? Effect of the Drug on Gas Exchange and Acute Ventilatory Hypoxic Response in Humans | 4.4 | 3 | Citations (PDF) |
| 116 | Autophagosome Proteins LC3A, LC3B and LC3C Have Distinct Subcellular Distribution Kinetics and Expression in Cancer Cell Lines | 2.5 | 138 | Citations (PDF) |
| 117 | Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition | 1.7 | 39 | Citations (PDF) |
| 118 | Hypoxia metabolism in ageing | 2.5 | 24 | Citations (PDF) |
| 119 | Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer | 7.7 | 114 | Citations (PDF) |
| 120 | Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress | 33.4 | 607 | Citations (PDF) |
| 121 | Metabolic and hypoxic adaptation to anti‐angiogenic therapy: a target for induced essentiality | 7.2 | 134 | Citations (PDF) |
| 122 | A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors | 6.4 | 130 | Citations (PDF) |
| 123 | A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis | 7.4 | 48 | Citations (PDF) |
| 124 | International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) | 2.0 | 45 | Citations (PDF) |
| 125 | Carbonic Anhydrase Activity Monitored <i>In Vivo</i> by Hyperpolarized 13C-Magnetic Resonance Spectroscopy Demonstrates Its Importance for pH Regulation in Tumors | 0.6 | 39 | Citations (PDF) |
| 126 | Increased expression of transcription factor EB (TFEB) is associated with autophagy, migratory phenotype and poor prognosis in non-small cell lung cancer | 2.1 | 74 | Citations (PDF) |
| 127 | Neoadjuvant Window Studies of Metformin and Biomarker Development for Drugs Targeting Cancer Metabolism | 2.0 | 7 | Citations (PDF) |
| 128 | Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1 and Relation to Clinical Response | 2.0 | 5 | Citations (PDF) |
| 129 | The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions | 7.7 | 60 | Citations (PDF) |
| 130 | The Role of Histone Demethylase KDM4B in Myc Signaling in Neuroblastoma | 5.1 | 62 | Citations (PDF) |
| 131 | MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast Cancer | 0.7 | 19 | Citations (PDF) |
| 132 | Incomplete Dll4/Notch signaling inhibition promotes functional angiogenesis supporting the growth of skin papillomas | 3.0 | 15 | Citations (PDF) |
| 133 | Scarring, stem cells, scaffolds and skin repair | 2.8 | 62 | Citations (PDF) |
| 134 | Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium | 5.3 | 88 | Citations (PDF) |
| 135 | Molecular Pathways: Translational and Therapeutic Implications of the Notch Signaling Pathway in Cancer | 6.4 | 140 | Citations (PDF) |
| 136 | Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways | 1.7 | 60 | Citations (PDF) |
| 137 | Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer | 1.7 | 33 | Citations (PDF) |
| 138 | Anoxia 2015, , 249-258 | | 0 | Citations (PDF) |
| 139 | Anoxia 2015, , 1-11 | | 0 | Citations (PDF) |
| 140 | Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer | 1.7 | 55 | Citations (PDF) |
| 141 | ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer | 1.7 | 67 | Citations (PDF) |
| 142 | JMY protein, a regulator of P53 and cytoplasmic actin filaments, is expressed in normal and neoplastic tissues | 2.7 | 11 | Citations (PDF) |
| 143 | Intracellular Carbonic Anhydrase Activity Sensitizes Cancer Cell pH Signaling to Dynamic Changes in CO2 Partial Pressure | 2.3 | 37 | Citations (PDF) |
| 144 | Autophagy and lysosomal related protein expression patterns in human glioblastoma | 4.3 | 77 | Citations (PDF) |
| 145 | Fatty Acid Uptake and Lipid Storage Induced by HIF-1α Contribute to Cell Growth and Survival after Hypoxia-Reoxygenation | 6.4 | 505 | Citations (PDF) |
| 146 | A review of ELTD1, a pro-angiogenic adhesion GPCR | 4.2 | 23 | Citations (PDF) |
| 147 | Fatty Acid-binding Protein 4, a Point of Convergence for Angiogenic and Metabolic Signaling Pathways in Endothelial Cells | 2.3 | 83 | Citations (PDF) |
| 148 | The Notch ligand Jagged1 as a target for anti-tumor therapy | 2.7 | 147 | Citations (PDF) |
| 149 | Informed Consent, Biobank Research, and Locality | 1.3 | 13 | Citations (PDF) |
| 150 | Functional comparison of Notch ligands in tumour angiogenesis | 0.5 | 0 | Citations (PDF) |
| 151 | Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia | 29.8 | 131 | Citations (PDF) |
| 152 | The chemistry, physiology and pathology of pH in cancer | 4.1 | 427 | Citations (PDF) |
| 153 | Inhibitors of Tumor Angiogenesis 2014, , 275-317 | | 1 | Citations (PDF) |
| 154 | Recurrent PTPRB and PLCG1 mutations in angiosarcoma | 16.3 | 256 | Citations (PDF) |
| 155 | When Cancer Co-opts the Vasculature | 25.5 | 3 | Citations (PDF) |
| 156 | Hypoxia and Metabolism in Cancer | 0.0 | 36 | Citations (PDF) |
| 157 | Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER | 14.1 | 194 | Citations (PDF) |
| 158 | TRAP1 Regulates Proliferation, Mitochondrial Function, and Has Prognostic Significance in NSCLC | 2.9 | 59 | Citations (PDF) |
| 159 | Glycogen metabolism in cancer | 5.1 | 80 | Citations (PDF) |
| 160 | The Hematopoietic Chemokine CXCL12 Promotes Integration of Human Endothelial Colony Forming Cell–Derived Cells into Immature Vessel Networks | 2.1 | 19 | Citations (PDF) |
| 161 | Seven In Absentia Homolog 2 (SIAH2) downregulation is associated with tamoxifen resistance in MCF-7 breast cancer cells | 1.8 | 10 | Citations (PDF) |
| 162 | Extensive regulation of the non‐coding transcriptome by hypoxia: role of
<scp>HIF</scp>
in releasing paused
<scp>RNA</scp>
pol2 | 5.3 | 137 | Citations (PDF) |
| 163 | Proline-Hydroxylated Hypoxia-Inducible Factor 1α (HIF-1α) Upregulation in Human Tumours | 2.5 | 35 | Citations (PDF) |
| 164 | Clinical Exploitation of Hypoxia | 0.0 | 0 | Citations (PDF) |
| 165 | Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts | 3.6 | 64 | Citations (PDF) |
| 166 | Erratum to “Microvessel networks pre-formed in artificial clinical grade dermal substitutes in vitro using cells from haematopoietic tissues” [Burns 38 (2012) 691–701] | 2.1 | 0 | Citations (PDF) |
| 167 | Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas | 0.7 | 11 | Citations (PDF) |
| 168 | A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis | 33.4 | 242 | Citations (PDF) |
| 169 | A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer | 6.4 | 188 | Citations (PDF) |
| 170 | A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours | 2.3 | 34 | Citations (PDF) |
| 171 | Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia | 4.2 | 96 | Citations (PDF) |
| 172 | An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3 | 3.3 | 12 | Citations (PDF) |
| 173 | Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth | 4.8 | 206 | Citations (PDF) |
| 174 | Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial | 0.9 | 52 | Citations (PDF) |
| 175 | New strategies for targeting the hypoxic tumour microenvironment in breast cancer | 10.1 | 167 | Citations (PDF) |
| 176 | Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma | 3.3 | 37 | Citations (PDF) |
| 177 | Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival | 3.9 | 126 | Citations (PDF) |
| 178 | The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis | 6.4 | 19 | Citations (PDF) |
| 179 | P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma | 5.1 | 67 | Citations (PDF) |
| 180 | Changing prognosis of renal cell carcinoma: a single-centre experience over 25 years | 0.3 | 0 | Citations (PDF) |
| 181 | Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment? | 2.8 | 226 | Citations (PDF) |
| 182 | The use of bio‐metal concentrations correlated with clinical prognostic factors to assess human breast tissues | 0.9 | 17 | Citations (PDF) |
| 183 | Molecular Basis for Jagged-1/Serrate Ligand Recognition by the Notch Receptor | 2.3 | 26 | Citations (PDF) |
| 184 | Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells<i>in vitro</i> | 5.3 | 76 | Citations (PDF) |
| 185 | Microenvironmental Induced Essentiality of Autophagy | 6.4 | 2 | Citations (PDF) |
| 186 | Regulation of Hypoxia Responses by MicroRNA Expression 2013, , 267-285 | | 0 | Citations (PDF) |
| 187 | The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity | 7.4 | 16 | Citations (PDF) |
| 188 | Targeting glycogen metabolism: a novel strategy to inhibit cancer cell growth? | 1.7 | 15 | Citations (PDF) |
| 189 | Molecular Chemotherapy for Breast Cancer | 3.5 | 8 | Citations (PDF) |
| 190 | Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer | 6.4 | 152 | Citations (PDF) |
| 191 | Metabolic compartments in tumor tissue: Implications for therapy | 3.2 | 4 | Citations (PDF) |
| 192 | Small-molecule inhibitors of the HIF pathway and synthetic lethal interactions | 3.9 | 16 | Citations (PDF) |
| 193 | Response: Re: Delta-Like Ligand 4-Notch Blockade and Tumor Radiation Response | 5.1 | 0 | Citations (PDF) |
| 194 | Acid-extrusion from Tissue: The Interplay Between Membrane Transporters and pH Buffers | 2.3 | 14 | Citations (PDF) |
| 195 | How cancer metabolism is tuned for proliferation and vulnerable to disruption | 40.1 | 771 | Citations (PDF) |
| 196 | Glucose Utilization via Glycogen Phosphorylase Sustains Proliferation and Prevents Premature Senescence in Cancer Cells | 26.3 | 307 | Citations (PDF) |
| 197 | ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer | 5.0 | 46 | Citations (PDF) |
| 198 | Targeting the ATF4 pathway in cancer therapy | 3.9 | 108 | Citations (PDF) |
| 199 | Microvessel networks in pre-formed in artificial clinical grade dermal substitutes in vitro using cells from haematopoietic tissues | 2.1 | 22 | Citations (PDF) |
| 200 | Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones | 8.5 | 70 | Citations (PDF) |
| 201 | Guidelines for the use and interpretation of assays for monitoring autophagy | 13.8 | 2,928 | Citations (PDF) |
| 202 | Clinical Imaging of Tumor Angiogenesis | 2.4 | 14 | Citations (PDF) |
| 203 | ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia | 2.6 | 26 | Citations (PDF) |
| 204 | Importance of Intracellular pH in Determining the Uptake and Efficacy of the Weakly Basic Chemotherapeutic Drug, Doxorubicin | 2.5 | 90 | Citations (PDF) |
| 205 | Gene Expression Analysis in Human Breast Cancer Associated Blood Vessels | 2.5 | 28 | Citations (PDF) |
| 206 | Targeting Carbonic Anhydrases with Fluorescent BODIPY‐Labelled Sulfonamides | 1.9 | 11 | Citations (PDF) |
| 207 | Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis<i>In Vivo</i>and Inhibition Enhances Anti-VEGF Therapy | 6.4 | 204 | Citations (PDF) |
| 208 | CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC | 2.9 | 47 | Citations (PDF) |
| 209 | Expression of vascular Notch ligands Delta‐like 4 and Jagged‐1 in glioblastoma | 3.9 | 40 | Citations (PDF) |
| 210 | High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC) | 7.4 | 15 | Citations (PDF) |
| 211 | Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression | 9.1 | 80 | Citations (PDF) |
| 212 | Gene expression and hypoxia in breast cancer | 9.9 | 72 | Citations (PDF) |
| 213 | microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer | 0.6 | 258 | Citations (PDF) |
| 214 | Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy | 6.4 | 117 | Citations (PDF) |
| 215 | Nuclear Localization of Factor Inhibitor Hypoxia-Inducible Factor in Prostate Cancer Is Associated With Poor Prognosis | 4.4 | 9 | Citations (PDF) |
| 216 | Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization | 25.6 | 524 | Citations (PDF) |
| 217 | miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors | 14.2 | 363 | Citations (PDF) |
| 218 | The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen | 5.0 | 21 | Citations (PDF) |
| 219 | Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers | 5.0 | 149 | Citations (PDF) |
| 220 | Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation | 0.9 | 148 | Citations (PDF) |
| 221 | Self assessment of health status and symptoms by cancer patients | 0.5 | 0 | Citations (PDF) |
| 222 | Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer | 6.4 | 81 | Citations (PDF) |
| 223 | New pathways and mechanisms regulating and responding to Delta-like ligand 4–Notch signalling in tumour angiogenesis | 4.2 | 15 | Citations (PDF) |
| 224 | Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis | 3.7 | 1,046 | Citations (PDF) |
| 225 | Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX | 4.4 | 36 | Citations (PDF) |
| 226 | The angiogenic process as a therapeutic target in cancer | 5.1 | 69 | Citations (PDF) |
| 227 | The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib | 2.3 | 27 | Citations (PDF) |
| 228 | Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas | 3.0 | 23 | Citations (PDF) |
| 229 | Notch3 signalling promotes tumour growth in colorectal cancer | 5.2 | 72 | Citations (PDF) |
| 230 | Expression of hypoxia‐associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the <i>VHL</i> gene | 5.2 | 36 | Citations (PDF) |
| 231 | Aberrant succination of proteins in fumarate hydratase‐deficient mice and HLRCC patients is a robust biomarker of mutation status | 5.2 | 232 | Citations (PDF) |
| 232 | Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor–Treated ER-Positive Breast Cancer | 6.4 | 27 | Citations (PDF) |
| 233 | Molecular Oncology and the Neoadjuvant Setting: the Perfect Blend for Treatment Personalization and Clinical Trial Design | 2.0 | 4 | Citations (PDF) |
| 234 | Delta-Like Ligand 4–Notch Blockade and Tumor Radiation Response | 5.1 | 53 | Citations (PDF) |
| 235 | Notch Regulation of Tumor Angiogenesis | 2.4 | 51 | Citations (PDF) |
| 236 | Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells | 7.7 | 168 | Citations (PDF) |
| 237 | DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy <i>In Vivo</i> | 0.6 | 197 | Citations (PDF) |
| 238 | International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010) | 2.0 | 57 | Citations (PDF) |
| 239 | Assessing Early Therapeutic Response to Bevacizumab in Primary Breast Cancer Using Magnetic Resonance Imaging and Gene Expression Profiles | 2.0 | 41 | Citations (PDF) |
| 240 | Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival | 2.9 | 10 | Citations (PDF) |
| 241 | Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer | 2.5 | 184 | Citations (PDF) |
| 242 | p21-activated kinase 1: PAK'ed with potential | 1.7 | 47 | Citations (PDF) |
| 243 | Anoxia 2011, , 193-198 | | 0 | Citations (PDF) |
| 244 | Diagnostic and Prognostic Cancer Biomarkers: From Traditional to Systems Approaches 2011, , 329-366 | | 0 | Citations (PDF) |
| 245 | Automated uro‐oncology data collection: the Cancer Research Uro‐Oncology Database | 3.5 | 7 | Citations (PDF) |
| 246 | New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomesBlood, 2010, 116, 2385-2394 | 1.0 | 332 | Citations (PDF) |
| 247 | Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells | 4.3 | 82 | Citations (PDF) |
| 248 | Synergistic activity of letrozole and sorafenib on breast cancer cells | 2.5 | 31 | Citations (PDF) |
| 249 | Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients | 2.5 | 11 | Citations (PDF) |
| 250 | Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinase | 5.1 | 18 | Citations (PDF) |
| 251 | Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis | 4.1 | 133 | Citations (PDF) |
| 252 | hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer | 4.4 | 213 | Citations (PDF) |
| 253 | Expression of key hypoxia sensing prolyl‐hydroxylases PHD1, ‐2 and ‐3 in pancreaticobiliary cancer | 3.9 | 34 | Citations (PDF) |
| 254 | Effects of HIF-1 and HIF2 on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts | 1.7 | 70 | Citations (PDF) |
| 255 | MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU | 2.5 | 267 | Citations (PDF) |
| 256 | Spectral Clustering of Microarray Data Elucidates the Roles of Microenvironment Remodeling and Immune Responses in Survival of Head and Neck Squamous Cell Carcinoma | 17.1 | 65 | Citations (PDF) |
| 257 | The Histone Demethylase JMJD2B Is Regulated by Estrogen Receptor α and Hypoxia, and Is a Key Mediator of Estrogen Induced Growth | 0.6 | 157 | Citations (PDF) |
| 258 | Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas | 1.7 | 79 | Citations (PDF) |
| 259 | Epigenetic downregulation of human disabled homolog 2 switches TGF-β from a tumor suppressor to a tumor promoter | 9.1 | 83 | Citations (PDF) |
| 260 | Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability | 0.6 | 165 | Citations (PDF) |
| 261 | HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer | 5.2 | 110 | Citations (PDF) |
| 262 | Targeting DLL4 in Tumors Shows Preclinical Activity But Potentially Significant Toxicity | 2.4 | 18 | Citations (PDF) |
| 263 | Expression of Vascular Notch Ligand Delta-Like 4 and Inflammatory Markers in Breast Cancer | 3.6 | 102 | Citations (PDF) |
| 264 | Roles of Tetrahydrobiopterin in Promoting Tumor Angiogenesis | 3.6 | 29 | Citations (PDF) |
| 265 | Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases | 8.5 | 46 | Citations (PDF) |
| 266 | Mechanisms of resistance to antiangiogenesis therapy | 3.3 | 140 | Citations (PDF) |
| 267 | 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance | 0.6 | 93 | Citations (PDF) |
| 268 | LC3A-Positive Light Microscopy Detected Patterns of Autophagy and Prognosis in Operable Breast Carcinomas | 3.6 | 93 | Citations (PDF) |
| 269 | Endothelial α3β1-Integrin Represses Pathological Angiogenesis and Sustains Endothelial-VEGF | 3.6 | 52 | Citations (PDF) |
| 270 | Biomarkers to predict the clinical efficacy of bevacizumab in cancer | 21.9 | 269 | Citations (PDF) |
| 271 | Human endothelial stem/progenitor cells, angiogenic factors and vascular repair | 3.4 | 49 | Citations (PDF) |
| 272 | The Role of Hypoxia Regulated microRNAs in Cancer | 0.0 | 30 | Citations (PDF) |
| 273 | Angiogenesis - still a worthwhile target for breast cancer therapy? | 5.0 | 11 | Citations (PDF) |
| 274 | A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data | 8.4 | 116 | Citations (PDF) |
| 275 | The Tumor Microenvironment: New Insights into Regulation of Tumor pH by Carbonic Anhydrases 2010, , 23-41 | | 1 | Citations (PDF) |
| 276 | Overexpression of <i>POLQ</i> Confers a Poor Prognosis in Early Breast Cancer Patients | 1.7 | 94 | Citations (PDF) |
| 277 | Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications | 6.5 | 106 | Citations (PDF) |
| 278 | Targeting the hypoxia-inducible factor (HIF) pathway in cancer | 4.9 | 178 | Citations (PDF) |
| 279 | Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer | 0.6 | 267 | Citations (PDF) |
| 280 | The Role of Carbonic Anhydrase 9 in Regulating Extracellular and Intracellular pH in Three-dimensional Tumor Cell Growths | 2.3 | 242 | Citations (PDF) |
| 281 | Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients | 6.4 | 132 | Citations (PDF) |
| 282 | Phase I/II Trial of Bevacizumab and Radiotherapy for Locally Advanced Inoperable Colorectal Cancer: Vasculature-Independent Radiosensitizing Effect of Bevacizumab | 6.4 | 49 | Citations (PDF) |
| 283 | Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer | 17.1 | 102 | Citations (PDF) |
| 284 | Exon Array Analysis of Head and Neck Cancers Identifies a Hypoxia Related Splice Variant of LAMA3 Associated with a Poor Prognosis | 3.3 | 39 | Citations (PDF) |
| 285 | A First-in-Man Phase I and Pharmacokinetic Study on CHR-2797 (Tosedostat), an Inhibitor of M1 Aminopeptidases, in Patients with Advanced Solid Tumors | 6.4 | 27 | Citations (PDF) |
| 286 | Contribution of Granulocyte Colony-Stimulating Factor to the Acute Mobilization of Endothelial Precursor Cells by Vascular Disrupting Agents | 0.6 | 74 | Citations (PDF) |
| 287 | The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib | 0.6 | 250 | Citations (PDF) |
| 288 | Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues | 3.2 | 74 | Citations (PDF) |
| 289 | Nuclear and membrane expression of the angiogenesis regulator delta‐like ligand 4 (DLL4) in normal and malignant human tissues | 3.9 | 16 | Citations (PDF) |
| 290 | Corrigendum | 3.9 | 0 | Citations (PDF) |
| 291 | Role of Hypoxia‐Inducible Factors in Epigenetic Regulation via Histone Demethylases | 4.5 | 92 | Citations (PDF) |
| 292 | Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms | 2.5 | 34 | Citations (PDF) |
| 293 | Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies | 5.3 | 161 | Citations (PDF) |
| 294 | Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3 | 0.9 | 78 | Citations (PDF) |
| 295 | Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxiaBlood, 2009, 114, 844-859 | 1.0 | 262 | Citations (PDF) |
| 296 | Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine | 4.7 | 40 | Citations (PDF) |
| 297 | Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies | 7.4 | 82 | Citations (PDF) |
| 298 | Expression of BNIP3 correlates with hypoxia‐inducible factor (HIF)‐1α, HIF‐2α and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines | 2.2 | 21 | Citations (PDF) |
| 299 | Phosphorylated VEGFR2/KDR receptors are widely expressed in B‐cell non‐Hodgkin's lymphomas and correlate with hypoxia inducible factor activation | 2.2 | 28 | Citations (PDF) |
| 300 | MicroRNA-10b and breast cancer metastasis | 40.1 | 125 | Citations (PDF) |
| 301 | Cancer-associated, hypoxia-inducible carbonic anhydrase IX facilitates CO2diffusion | 3.5 | 57 | Citations (PDF) |
| 302 | Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma | 2.7 | 1,473 | Citations (PDF) |
| 303 | The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer | 1.6 | 79 | Citations (PDF) |
| 304 | Hypoxia response and microRNAs: no longer two separate worlds | 4.1 | 170 | Citations (PDF) |
| 305 | Evaluation of the current knowledge limitations in breast cancer research: a gap analysis | 5.0 | 82 | Citations (PDF) |
| 306 | Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors | 6.4 | 85 | Citations (PDF) |
| 307 | Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells | 2.5 | 174 | Citations (PDF) |
| 308 | Activating transcription factor 4 | 2.6 | 414 | Citations (PDF) |
| 309 | Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway | 8.5 | 21 | Citations (PDF) |
| 310 | Targeting tumour hypoxia in breast cancer | 3.3 | 66 | Citations (PDF) |
| 311 | Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins | 1.6 | 16 | Citations (PDF) |
| 312 | A Five-Gene Molecular Grade Index and <i>HOXB13:IL17BR</i> Are Complementary Prognostic Factors in Early Stage Breast Cancer | 6.4 | 265 | Citations (PDF) |
| 313 | BHLHB2 Controls<i>Bdnf</i>Promoter 4 Activity and Neuronal Excitability | 3.7 | 79 | Citations (PDF) |
| 314 | Down-Regulation of Phosphatidylinositol 3′-Kinase/AKT/Molecular Target of Rapamycin Metabolic Pathway by Primary Letrozole-Based Therapy in Human Breast Cancer | 6.4 | 49 | Citations (PDF) |
| 315 | Inhibitors of tumor angiogenesis 2008, , 351-381 | | 0 | Citations (PDF) |
| 316 | Tumor-associated Carbonic Anhydrase 9 Spatially Coordinates Intracellular pH in Three-dimensional Multicellular Growths | 2.3 | 181 | Citations (PDF) |
| 317 | Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors | 6.4 | 334 | Citations (PDF) |
| 318 | Regulation of CXCR4 by the Notch Ligand Delta-like 4 in Endothelial Cells | 0.6 | 53 | Citations (PDF) |
| 319 | hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer | 6.4 | 567 | Citations (PDF) |
| 320 | Measuring Angiogenic Cytokines, Circulating Endothelial Cells, and Endothelial Progenitor Cells in Peripheral Blood and Cord Blood: VEGF and CXCL12 Correlate with the Number of Circulating Endothelial Progenitor Cells in Peripheral Blood | 2.6 | 28 | Citations (PDF) |
| 321 | Macrophage Infiltration and Angiogenesis in Human Malignancy | 1.0 | 55 | Citations (PDF) |
| 322 | HER2 Oncogenic Function Escapes EGFR Tyrosine Kinase Inhibitors via Activation of Alternative HER Receptors in Breast Cancer Cells | 2.5 | 65 | Citations (PDF) |
| 323 | Hypoxic Regulation of Angiogenesis by HIF-1 2008, , 169-179 | | 0 | Citations (PDF) |
| 324 | The Unfolded Protein Response and Integrated Stress Response to Anoxia: Fig. 1. | 6.4 | 45 | Citations (PDF) |
| 325 | Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade | 17.1 | 665 | Citations (PDF) |
| 326 | Relation of a Hypoxia Metagene Derived from Head and Neck Cancer to Prognosis of Multiple Cancers | 0.6 | 306 | Citations (PDF) |
| 327 | BNIP3 as a Progression Marker in Primary Human Breast Cancer; Opposing Functions in In situ Versus Invasive Cancer | 6.4 | 78 | Citations (PDF) |
| 328 | Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast Cancer | 6.4 | 12 | Citations (PDF) |
| 329 | 177Lu-labeled-VG76e monoclonal antibody in tumor angiogenesis: A comparative study using DOTA and DTPA chelating systems | 1.4 | 9 | Citations (PDF) |
| 330 | Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth <i>In vivo</i> | 0.6 | 269 | Citations (PDF) |
| 331 | Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series | 6.4 | 776 | Citations (PDF) |
| 332 | Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma | 8.5 | 44 | Citations (PDF) |
| 333 | Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis? | 10.0 | 64 | Citations (PDF) |
| 334 | Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data | 21.9 | 61 | Citations (PDF) |
| 335 | An Investigation Into the Prognostic Significance of Necrosis and Hypoxia in High Grade and Invasive Bladder Cancer | 4.4 | 51 | Citations (PDF) |
| 336 | Breast tumour angiogenesis | 5.0 | 141 | Citations (PDF) |
| 337 | Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer | 5.0 | 38 | Citations (PDF) |
| 338 | Transcriptional Profiling of Human Cord Blood CD133+ and Cultured Bone Marrow Mesenchymal Stem Cells in Response to Hypoxia | 3.3 | 142 | Citations (PDF) |
| 339 | Macrophages and the hypoxic tumour microenvironment | 6.5 | 61 | Citations (PDF) |
| 340 | The number of regulatory T cells in prostate cancer is associated with the androgen receptor and hypoxia-inducible factor (HIF)-2α but not HIF-1α | 2.2 | 27 | Citations (PDF) |
| 341 | Expression of theforkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the Androgen receptor in prostate cancer but is not directly regulated by Androgens or hypoxia | 2.2 | 38 | Citations (PDF) |
| 342 | Regulation of tumor pH and the role of carbonic anhydrase 9 | 7.2 | 452 | Citations (PDF) |
| 343 | The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer | 7.2 | 103 | Citations (PDF) |
| 344 | Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptorβ in primary invasive breast carcinomas | 2.5 | 45 | Citations (PDF) |
| 345 | Carbonic anhydrase IX unifies spatial pH
<sub>i</sub>
regulation in large cell‐clusters | 0.7 | 0 | Citations (PDF) |
| 346 | In vivo assessment of Delta like‐4 function in tumour development | 0.7 | 0 | Citations (PDF) |
| 347 | Gorham-Stout Syndrome: A Monocyte-Mediated Cytokine Propelled Disease | 5.1 | 61 | Citations (PDF) |
| 348 | Introduction on Angiogenesis in Breast Cancer | 3.2 | 0 | Citations (PDF) |
| 349 | The Role of Copper in Tumour Angiogenesis | 3.2 | 155 | Citations (PDF) |
| 350 | Mechanisms of Disease: angiogenesis in urologic malignancies | 1.7 | 44 | Citations (PDF) |
| 351 | Comparison of Metabolic Pathways between Cancer Cells and Stromal Cells in Colorectal Carcinomas: a Metabolic Survival Role for Tumor-Associated Stroma | 0.6 | 370 | Citations (PDF) |
| 352 | Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis | 5.1 | 1,656 | Citations (PDF) |
| 353 | C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1α gene define HIF-1α protein expression in non-small cell lung cancer | 2.1 | 33 | Citations (PDF) |
| 354 | Nuclear Factor-κB Signature of Inflammatory Breast Cancer by cDNA Microarray Validated by Quantitative Real-time Reverse Transcription-PCR, Immunohistochemistry, and Nuclear Factor-κB DNA-Binding | 6.4 | 96 | Citations (PDF) |
| 355 | Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse | 17.1 | 955 | Citations (PDF) |
| 356 | Hypoxia-regulated differentiation: let's step it up a Notch | 10.0 | 54 | Citations (PDF) |
| 357 | The Role of Cell-Free DNA Size Distribution in the Management of Prostate Cancer | 3.3 | 26 | Citations (PDF) |
| 358 | Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell functionBlood, 2006, 107, 931-939 | 1.0 | 300 | Citations (PDF) |
| 359 | Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma | 3.8 | 52 | Citations (PDF) |
| 360 | Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer | 4.0 | 52 | Citations (PDF) |
| 361 | Phosphorylated KDR expression in endometrial cancer cells relates to HIF1α/VEGF pathway and unfavourable prognosis | 5.0 | 36 | Citations (PDF) |
| 362 | Phosphorylated KDR can be located in the nucleus of neoplastic cells | 8.2 | 32 | Citations (PDF) |
| 363 | Normoxic Stabilization of Hypoxia-Inducible Factor-1α by Modulation of the Labile Iron Pool in Differentiating U937 Macrophages: Effect of Natural Resistance–Associated Macrophage Protein 1 | 0.6 | 81 | Citations (PDF) |
| 364 | Notch Signaling in Breast Cancer and Tumor Angiogenesis: Cross-Talk and Therapeutic Potentials | 3.2 | 62 | Citations (PDF) |
| 365 | Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis | 1.6 | 86 | Citations (PDF) |
| 366 | Niacin induces PPARγ expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways | 5.1 | 84 | Citations (PDF) |
| 367 | Molecular profiling of signalling proteins for effects induced by the anti-cancer compound GSAO with 400 antibodies | 3.0 | 4 | Citations (PDF) |
| 368 | The relation between hypoxia‐inducible factor (HIF)‐1α and HIF‐2α expression with anemia and outcome in surgically treated head and neck cancer | 4.4 | 82 | Citations (PDF) |
| 369 | Impact of cyclins E, neutrophil elastase and proteinase 3 expression levels on clinical outcome in primary breast cancer patients | 4.5 | 36 | Citations (PDF) |
| 370 | Effects of Transferrin Receptor Blockade on Cancer Cell Proliferation and Hypoxia-Inducible Factor Function and Their Differential Regulation by Ascorbate | 0.6 | 63 | Citations (PDF) |
| 371 | Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer | 5.1 | 1,011 | Citations (PDF) |
| 372 | Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer | 6.4 | 214 | Citations (PDF) |
| 373 | Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide As Primary Systemic Treatment in Elderly Breast Cancer Patients | 17.1 | 164 | Citations (PDF) |
| 374 | Lactate Dehydrogenase 5 Expression in Operable Colorectal Cancer: Strong Association With Survival and Activated Vascular Endothelial Growth Factor Pathway—A Report of the Tumour Angiogenesis Research Group | 17.1 | 176 | Citations (PDF) |
| 375 | Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial | 17.1 | 243 | Citations (PDF) |
| 376 | Novel Thioredoxin Inhibitors Paradoxically Increase Hypoxia-Inducible Factor-α Expression but Decrease Functional Transcriptional Activity, DNA Binding, and Degradation | 6.4 | 43 | Citations (PDF) |
| 377 | Prognostic Value of an Activation State Marker for Epidermal Growth Factor Receptor in Tissue Microarrays of Head and Neck Cancer | 0.6 | 48 | Citations (PDF) |
| 378 | Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding | 1.7 | 57 | Citations (PDF) |
| 379 | Up-Regulation of Endothelial Delta-like 4 Expression Correlates with Vessel Maturation in Bladder Cancer | 6.4 | 120 | Citations (PDF) |
| 380 | Hypoxia-induced genetic instability—a calculated mechanism underlying tumor progression | 3.6 | 122 | Citations (PDF) |
| 381 | Biological Therapies for Metastatic Breast Cancer: Antiangiogenesis 2006, , 671-704 | | 0 | Citations (PDF) |
| 382 | Notch signaling from tumor cells: A new mechanism of angiogenesis | 33.4 | 106 | Citations (PDF) |
| 383 | Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence | 4.5 | 84 | Citations (PDF) |
| 384 | Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis | 2.4 | 137 | Citations (PDF) |
| 385 | Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium ?Breast Cancer ? the Development and Validation of New Therapeutics? | 2.5 | 5 | Citations (PDF) |
| 386 | Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival | 5.2 | 42 | Citations (PDF) |
| 387 | Housekeeping proteins: A preliminary study illustrating some limitations as useful references in protein expression studies | 3.8 | 199 | Citations (PDF) |
| 388 | Antiangiogenic Therapy 2005, , | | 0 | Citations (PDF) |
| 389 | Relation of Erythropoietin and Erythropoietin Receptor Expression to Hypoxia and Anemia in Head and Neck Squamous Cell Carcinoma | 6.4 | 38 | Citations (PDF) |
| 390 | Antiangiogenic Activity of a Domain Deletion Mutant of Tissue Plasminogen Activator Containing Kringle 2 | 6.2 | 10 | Citations (PDF) |
| 391 | Up-regulation of Delta-like 4 Ligand in Human Tumor Vasculature and the Role of Basal Expression in Endothelial Cell Function | 0.6 | 305 | Citations (PDF) |
| 392 | The Role of Hypoxia-Inducible Factor-1 in Three-dimensional Tumor Growth, Apoptosis, and Regulation by the Insulin-Signaling Pathway | 0.6 | 38 | Citations (PDF) |
| 393 | Phase I Study of MetXia-P450 Gene Therapy and Oral Cyclophosphamide for Patients with Advanced Breast Cancer or Melanoma | 6.4 | 84 | Citations (PDF) |
| 394 | The Androgen Receptor Is Significantly Associated with Vascular Endothelial Growth Factor and Hypoxia Sensing via Hypoxia-Inducible Factors HIF-1a, HIF-2a, and the Prolyl Hydroxylases in Human Prostate Cancer | 6.4 | 132 | Citations (PDF) |
| 395 | Prospective Study of Quantitation of Plasma DNA Levels in the Diagnosis of Malignant versus Benign Prostate Disease | 6.4 | 93 | Citations (PDF) |
| 396 | Temozolomide Pharmacodynamics in Patients with Metastatic Melanoma: DNA Damage and Activity of Repair Enzymes O6-Alkylguanine Alkyltransferase and Poly(ADP-Ribose) Polymerase-1 | 6.4 | 96 | Citations (PDF) |
| 397 | Inclusion of Vasculature-Related Variables in the Dukes Staging System of Colon Cancer | 6.4 | 32 | Citations (PDF) |
| 398 | Immunodominance of Poxviral-Specific CTL in a Human Trial of Recombinant-Modified Vaccinia Ankara | 0.6 | 91 | Citations (PDF) |
| 399 | Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells | 3.6 | 26 | Citations (PDF) |
| 400 | Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1 | 0.9 | 115 | Citations (PDF) |
| 401 | HIF-2α expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia | 3.1 | 67 | Citations (PDF) |
| 402 | Pyruvate Dehydrogenase and Pyruvate Dehydrogenase Kinase Expression in Non Small Cell Lung Cancer and Tumor-Associated Stroma | 7.2 | 173 | Citations (PDF) |
| 403 | Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma | 2.5 | 791 | Citations (PDF) |
| 404 | HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression | 14.2 | 296 | Citations (PDF) |
| 405 | Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1α expression | 5.0 | 44 | Citations (PDF) |
| 406 | Metabolic profiling of hypoxia-inducible factor-1β-deficient and wild type Hepa-1 cells: effects of hypoxia measured by 1H magnetic resonance spectroscopy | 2.8 | 12 | Citations (PDF) |
| 407 | Increased Angiogenesis and Lymphangiogenesis in Inflammatory versus Noninflammatory Breast Cancer by Real-Time Reverse Transcriptase-PCR Gene Expression Quantification | 6.4 | 201 | Citations (PDF) |
| 408 | Activation of Peroxisome Proliferator-Activated Receptor δ Stimulates the Proliferation of Human Breast and Prostate Cancer Cell Lines | 0.6 | 155 | Citations (PDF) |
| 409 | Novel Mechanism of Action for Hydralazine | 12.8 | 120 | Citations (PDF) |
| 410 | BNIP3 Expression Is Linked with Hypoxia-Regulated Protein Expression and with Poor Prognosis in Non–Small Cell Lung Cancer | 6.4 | 114 | Citations (PDF) |
| 411 | A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast Cancer | 6.4 | 177 | Citations (PDF) |
| 412 | c-Myc Interacts with Hypoxia to Induce Angiogenesis In vivo by a Vascular Endothelial Growth Factor-Dependent Mechanism | 0.6 | 80 | Citations (PDF) |
| 413 | c-erbB-2 Related Aggressiveness in Breast Cancer Is Hypoxia Inducible Factor-1α Dependent | 6.4 | 73 | Citations (PDF) |
| 414 | Antiangiogenic Therapy for von Hippel-Lindau Disease | 13.7 | 60 | Citations (PDF) |
| 415 | CITED4 Inhibits Hypoxia-Activated Transcription in Cancer Cells, and Its Cytoplasmic Location in Breast Cancer Is Associated with Elevated Expression of Tumor Cell Hypoxia-Inducible Factor 1α | 0.6 | 57 | Citations (PDF) |
| 416 | Hypoxia-Inducible Factor 1α Expression as an Intrinsic Marker of Hypoxia | 6.4 | 116 | Citations (PDF) |
| 417 | Expression of Hypoxia-related Tissue Factors Correlates with Diminished Survival of Adjuvantly Treated Patients with Chromosome 1p Aberrant Oligodendroglial Neoplasms and Therapeutic Implications | 6.4 | 12 | Citations (PDF) |
| 418 | Noninvasive Measurements of Capecitabine Metabolism in Bladder Tumors Overexpressing Thymidine Phosphorylase by Fluorine-19 Magnetic Resonance Spectroscopy | 6.4 | 17 | Citations (PDF) |
| 419 | Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy | 9.1 | 145 | Citations (PDF) |
| 420 | Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor α and Improved Survival in Primary Human Breast Carcinomas | 6.4 | 82 | Citations (PDF) |
| 421 | Histological quantitation of tumour angiogenesisApmis, 2004, 112, 413-430 | 2.6 | 124 | Citations (PDF) |
| 422 | Measuring tumor pharmacodynamic response using PET proliferation probes: the case for 2-[11C]-thymidine | 7.1 | 6 | Citations (PDF) |
| 423 | Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor | 2.3 | 878 | Citations (PDF) |
| 424 | Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer | 0.7 | 37 | Citations (PDF) |
| 425 | Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus | 5.2 | 50 | Citations (PDF) |
| 426 | The hypoxia-regulated transcription factor DEC1(Stra13, SHARP-2) and its expression in human tissues and tumours | 5.2 | 54 | Citations (PDF) |
| 427 | Non-linear survival analysis using neural networks | 1.7 | 59 | Citations (PDF) |
| 428 | Hypoxia-inducible factor-1? in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathways | 4.5 | 138 | Citations (PDF) |
| 429 | Role of Carbonic Anhydrase IX in Human Tumor Cell Growth, Survival, and Invasion | 0.6 | 251 | Citations (PDF) |
| 430 | Hypoxia-inducible factors and hypoxic cell death in tumour physiology | 3.9 | 101 | Citations (PDF) |
| 431 | NOVELANGIOGENICSIGNALINGPATHWAYS ANDVASCULARTARGETS | 12.4 | 87 | Citations (PDF) |
| 432 | Hypoxia Inducible Carbonic Anhydrase IX, Marker of Tumour: Hypoxia, Survival Pathway and Therapy Target | 3.2 | 230 | Citations (PDF) |
| 433 | Anoxic induction of ATF-4 through HIF-1–independent pathways of protein stabilization in human cancer cellsBlood, 2004, 103, 1876-1882 | 1.0 | 156 | Citations (PDF) |
| 434 | Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer | 6.6 | 79 | Citations (PDF) |
| 435 | Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival | 7.9 | 31 | Citations (PDF) |
| 436 | High Serum YKL-40 Levels in Patients with Primary Breast Cancer is Related to Short Recurrence Free Survival | 2.5 | 107 | Citations (PDF) |
| 437 | Necrosis and Hypoxia in Invasive Breast Carcinoma | 2.5 | 95 | Citations (PDF) |
| 438 | The Presence of a Fibrotic Focus in Invasive Breast Carcinoma Correlates with the Expression of Carbonic Anhydrase IX and is a Marker of Hypoxia and Poor Prognosis | 2.5 | 104 | Citations (PDF) |
| 439 | GLUT‐1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding | 4.5 | 189 | Citations (PDF) |
| 440 | A population pharmacokinetic model for paclitaxel in the presence of a novel P-gp modulator, Zosuquidar Trihydrochloride (LY335979) | 2.8 | 22 | Citations (PDF) |
| 441 | DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer | 5.2 | 75 | Citations (PDF) |
| 442 | Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer | 5.2 | 167 | Citations (PDF) |
| 443 | Expression of the cell death genes BNip3 and NIX in ductal carcinomain situ of the breast; correlation of BNip3 levels with necrosis and grade | 5.2 | 106 | Citations (PDF) |
| 444 | Title is missing! | 4.6 | 156 | Citations (PDF) |
| 445 | Breast cancer classification and prognosis based on gene expression profiles from a population-based study | 7.7 | 1,636 | Citations (PDF) |
| 446 | Comprehensive Proteomic Analysis of Breast Cancer Cell Membranes Reveals Unique Proteins with Potential Roles in Clinical Cancer | 2.3 | 170 | Citations (PDF) |
| 447 | Non-Nuclear Localized Human NOSII Enhances the Bioactivation and Toxicity of Tirapazamine (SR4233) in Vitro | 2.8 | 25 | Citations (PDF) |
| 448 | NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells | 0.6 | 417 | Citations (PDF) |
| 449 | Carbonic Anhydrase IX Expression, a Novel Surrogate Marker of Tumor Hypoxia, Is Associated With a Poor Prognosis in Non–Small-Cell Lung Cancer | 17.1 | 239 | Citations (PDF) |
| 450 | Angiogenesis in Endocrine Tumors | 26.0 | 220 | Citations (PDF) |
| 451 | Hypoxia-inducible factors 1?? and 2?? are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin | 1.5 | 142 | Citations (PDF) |
| 452 | High-dose i.v. granisetron for the prevention of chemotherapy-induced emesis: cardiac safety and tolerability | 1.5 | 10 | Citations (PDF) |
| 453 | The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy | 2.3 | 19 | Citations (PDF) |
| 454 | Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1α | 2.3 | 26 | Citations (PDF) |
| 455 | Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic Subtypes | 4.7 | 120 | Citations (PDF) |
| 456 | Thymidine Phosphorylase Expression in Gallbladder Adenocarcinomas | 1.0 | 11 | Citations (PDF) |
| 457 | Differential Gene Expression Patterns in HER2/neu-Positive and -Negative Breast Cancer Cell Lines and Tissues | 3.6 | 90 | Citations (PDF) |
| 458 | ROLE OF THYMIDINE PHOSPHORYLASE IN AN IN VITRO MODEL OF HUMAN BLADDER CANCER INVASION | 4.4 | 17 | Citations (PDF) |
| 459 | Drug inhibition of angiogenesis | 4.1 | 62 | Citations (PDF) |
| 460 | HIF activation identifies early lesions in VHL kidneys | 33.4 | 434 | Citations (PDF) |
| 461 | Angiogenesis in bladder cancer—prognostic marker and target for future therapy | 2.1 | 46 | Citations (PDF) |
| 462 | Preparation of the iodine-124 derivative of the Bolton-Hunter reagent ([124I]I-SHPP) and its use for labelling a VEGF antibody as a PET tracer | 0.9 | 11 | Citations (PDF) |
| 463 | Association of hypoxia‐inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma | 4.4 | 191 | Citations (PDF) |
| 464 | Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer | 0.7 | 284 | Citations (PDF) |
| 465 | Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas | 5.2 | 47 | Citations (PDF) |
| 466 | Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2 | 5.2 | 98 | Citations (PDF) |
| 467 | Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel‐Lindau gene and hypoxia | 5.2 | 80 | Citations (PDF) |
| 468 | A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis | 6.6 | 72 | Citations (PDF) |
| 469 | Hypoxia — a key regulatory factor in tumour growth | 24.2 | 4,408 | Citations (PDF) |
| 470 | Title is missing! | 3.2 | 307 | Citations (PDF) |
| 471 | Title is missing! | 2.9 | 12 | Citations (PDF) |
| 472 | Diagnostic and Prognostic Significance of Tumor Angiogenesis 2002, , 151-176 | | 1 | Citations (PDF) |
| 473 | ROLE OF THYMIDINE PHOSPHORYLASE IN AN IN VITRO MODEL OF HUMAN BLADDER CANCER INVASION | 4.4 | 1 | Citations (PDF) |
| 474 | Hypoxia and oxidative stress in breast cancer Hypoxia and tumourigenesis | 5.0 | 94 | Citations (PDF) |
| 475 | Measurement of Microvessel Density in Primary Tumors 2001, , 115-121 | | 2 | Citations (PDF) |
| 476 | Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast | 3.6 | 204 | Citations (PDF) |
| 477 | Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs | 21.9 | 211 | Citations (PDF) |
| 478 | Angiogenesis as a biomarker and target in cancer chemoprevention | 21.9 | 66 | Citations (PDF) |
| 479 | Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma | 17.1 | 377 | Citations (PDF) |
| 480 | 8-Cl-adenosine is an active metabolite of 8-Cl-cAMP responsible for its in vitro antiproliferative effects on CHO mutants hypersensitive to cytostatic drugs | 2.3 | 11 | Citations (PDF) |
| 481 | Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome | 0.7 | 100 | Citations (PDF) |
| 482 | VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis | 5.2 | 49 | Citations (PDF) |
| 483 | The angiogenic pathway ?vascular endothelial growth factor/flk-1(KDR)-receptor? in rheumatoid arthritis and osteoarthritis | 5.2 | 82 | Citations (PDF) |
| 484 | Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer | 5.2 | 39 | Citations (PDF) |
| 485 | The angiogenic ?vascular endothelial growth factor/flk-1(KDR) receptor? pathway in patients with endometrial carcinoma | 4.4 | 66 | Citations (PDF) |
| 486 | Delta4, an endothelial specific Notch ligand expressed at sites of physiological and tumor angiogenesis | 2.4 | 246 | Citations (PDF) |
| 487 | Detection of Mammaglobin mRNA in the Plasma of Breast Cancer Patients | 4.5 | 25 | Citations (PDF) |
| 488 | The HIF Pathway: Implications for Patterns of Gene Expression in Cancer | 1.0 | 41 | Citations (PDF) |
| 489 | Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer | 5.2 | 262 | Citations (PDF) |
| 490 | ‘Invading edge vs. inner’ (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer | 5.2 | 51 | Citations (PDF) |
| 491 | Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling | 6.6 | 226 | Citations (PDF) |
| 492 | The relative importance of NADPH: cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions | 5.1 | 37 | Citations (PDF) |
| 493 | Title is missing! | 2.9 | 8 | Citations (PDF) |
| 494 | Cid1, a Fission Yeast Protein Required for S-M Checkpoint Control when DNA Polymerase δ or ɛ Is Inactivated | 2.5 | 58 | Citations (PDF) |
| 495 | Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen | 2.3 | 16 | Citations (PDF) |
| 496 | Angiogenesis in Pituitary Adenomas and the Normal Pituitary Gland | 4.4 | 136 | Citations (PDF) |
| 497 | A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response | 0.6 | 121 | Citations (PDF) |
| 498 | von Hippel‐Lindau Syndrome: Target for Anti‐Vascular Endothelial Growth Factor (VEGF) Receptor Therapy | 3.6 | 49 | Citations (PDF) |
| 499 | The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages | 3.6 | 1,116 | Citations (PDF) |
| 500 | Platelet-derived endothelial cell growth factor expression and angiogenesis in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix | 1.2 | 18 | Citations (PDF) |
| 501 | Hypoxia signalling in tumour angiogenesis | 1.0 | 3 | Citations (PDF) |
| 502 | c-erbB-2 and Episialin Challenge Host Immune Response by HLA Class I Expression in Human Non–Small-Cell Lung Cancer | 2.4 | 10 | Citations (PDF) |
| 503 | Angiogenesis in Pituitary Adenomas and the Normal Pituitary Gland | 4.4 | 38 | Citations (PDF) |
| 504 | von Hippel-Lindau Syndrome: Target for Anti-Vascular Endothelial Growth Factor (VEGF) Receptor Therapy | 3.6 | 3 | Citations (PDF) |
| 505 | Title is missing! | 2.9 | 23 | Citations (PDF) |
| 506 | Title is missing! | 2.9 | 44 | Citations (PDF) |
| 507 | MDM2 and MDMX bind and stabilize the p53-related protein p73 | 3.9 | 108 | Citations (PDF) |
| 508 | Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma | 4.4 | 28 | Citations (PDF) |
| 509 | Combined role of tumor angiogenesis,bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma 1999, 86, 1421-1430 | | 73 | Citations (PDF) |
| 510 | Angiogenesisvs. response after combined chemoradiotherapy of squamous cell head and neck cancer 1999, 80, 810-817 | | 32 | Citations (PDF) |
| 511 | Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC) 1999, 189, 351-357 | | 40 | Citations (PDF) |
| 512 | URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS CORRELATION WITH BLADDER CANCER RECURRENCE RATES | 4.4 | 113 | Citations (PDF) |
| 513 | eIF4E expression in tumors: its possible role in progression of malignancies | 2.6 | 297 | Citations (PDF) |
| 514 | Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis | 8.5 | 25 | Citations (PDF) |
| 515 | Vascular endothelial growth factor platelet counts, and prognosis in renal cancer | 35.3 | 54 | Citations (PDF) |
| 516 | Title is missing! 1999 | | 2 | Citations (PDF) |
| 517 | Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma | 4.4 | 61 | Citations (PDF) |
| 518 | Prognostic Significance of Tumor Vascularity 1999, , 317-339 | | 12 | Citations (PDF) |
| 519 | URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS CORRELATION WITH BLADDER CANCER RECURRENCE RATES | 4.4 | 3 | Citations (PDF) |
| 520 | Title is missing! 1998, 17, 187-194 | | 116 | Citations (PDF) |
| 521 | Insulin-like growth factors in human breast cancer | 2.5 | 73 | Citations (PDF) |
| 522 | Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful? | 2.5 | 160 | Citations (PDF) |
| 523 | Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation | 2.9 | 17 | Citations (PDF) |
| 524 | Title is missing! | 7.4 | 6 | Citations (PDF) |
| 525 | Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines 1998, 75, 706-712 | | 51 | Citations (PDF) |
| 526 | Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium 1998, 185, 402-408 | | 61 | Citations (PDF) |
| 527 | Expression of VEGF in routinely fixed material using a new monoclonal 1998, 186, 313-318 | | 64 | Citations (PDF) |
| 528 | Are angiostatin and endostatin cures for cancer? | 35.3 | 32 | Citations (PDF) |
| 529 | Anti-angiogenic therapies in cancer clinical trials | 4.1 | 14 | Citations (PDF) |
| 530 | Angiogenic Polypeptides in Breast Cancer: Expression of Mrna’s in Primary Human Tumours, MCF-7 Cell Transfection and Xenograft Models 1998, , 213-221 | | 1 | Citations (PDF) |
| 531 | A Novel Cyclic Adenosine Monophosphate Analog Induces Hypercalcemia via Production of 1,25-Dihydroxyvitamin D in Patients with Solid Tumors | 4.4 | 20 | Citations (PDF) |
| 532 | Resistance to Diverse Drugs and Ultraviolet Light Conferred by Overexpression of a Novel Human 26 S Proteasome Subunit | 2.3 | 73 | Citations (PDF) |
| 533 | Association of Tumor Angiogenesis With Bone Marrow Micrometastases in Breast Cancer Patients | 5.1 | 98 | Citations (PDF) |
| 534 | Endothelial Cell-Specific Expression of Tumor Necrosis Factor-<i>α</i>from the KDR or E-Selectin Promoters Following Retroviral Delivery | 3.4 | 50 | Citations (PDF) |
| 535 | cDNA Cloning of a Humandishevelled DVL-3Gene, Mapping to 3q27, and Expression in Human Breast and Colon Carcinomas | 2.1 | 20 | Citations (PDF) |
| 536 | Expression of Wnt5a Is Downregulated by Extracellular Matrix and Mutated c-Ha-ras in the Human Mammary Epithelial Cell Line MCF-10A | 2.1 | 23 | Citations (PDF) |
| 537 | Antiangiogenesis for cancer therapy | 35.3 | 111 | Citations (PDF) |
| 538 | Isolation of a full-length human WNT7A gene implicated in limb development and cell transformation, and mapping to chromosome 3p25 | 2.4 | 20 | Citations (PDF) |
| 539 | A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas | 6.6 | 80 | Citations (PDF) |
| 540 | Targeting gene expression to hypoxic tumor cells | 25.6 | 324 | Citations (PDF) |
| 541 | Title is missing! | 3.2 | 45 | Citations (PDF) |
| 542 | Title is missing! 1997, 15, 15-28 | | 59 | Citations (PDF) |
| 543 | Title is missing! | 7.4 | 12 | Citations (PDF) |
| 544 | Platelet-derived endothelial cell growth factor (Thymidine Phosphorylase) expression in lung cancer 1997, 181, 196-199 | | 50 | Citations (PDF) |
| 545 | Potential role ofbcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer 1997, 74, 565-570 | | 52 | Citations (PDF) |
| 546 | Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up | 2.4 | 88 | Citations (PDF) |
| 547 | Mechanisms and therapeutic implications of angiogenesis | 2.3 | 61 | Citations (PDF) |
| 548 | Breast cancer angiogenesis — new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting | 2.5 | 47 | Citations (PDF) |
| 549 | EARLY EXPRESSION OF bcl-2 PROTEIN IN THE ADENOMA-CARCINOMA SEQUENCE OF COLORECTAL NEOPLASIA 1996, 179, 10-14 | | 50 | Citations (PDF) |
| 550 | PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER | 5.2 | 133 | Citations (PDF) |
| 551 | TUMOUR ANGIOGENESIS 1996, 179, 232-237 | | 116 | Citations (PDF) |
| 552 | Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target | 7.2 | 16 | Citations (PDF) |
| 553 | p53 Regulates the Minimal Promoter of the Human Topoisomerase II Gene | 16.2 | 78 | Citations (PDF) |
| 554 | Regulation of the Human Topoisomerase IIα Gene Promoter in Confluence-arrested Cells | 2.3 | 78 | Citations (PDF) |
| 555 | Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas | 2.5 | 75 | Citations (PDF) |
| 556 | An open study to assess the safety, tolerance and pharmacokinetics of an intravenous infusion of granisetron given at 3 mg over 30 s in patients receiving chemotherapy for malignant disease | 2.3 | 24 | Citations (PDF) |
| 557 | Platelet‐derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study | 5.2 | 165 | Citations (PDF) |
| 558 | Microvessel count predicts metastatic disease and survival in non‐small cell lung cancer | 5.2 | 152 | Citations (PDF) |
| 559 | Regulation of Wnt5a mRNA Expression in Human Mammary Epithelial Cells by Cell Shape, Confluence, and Hepatocyte Growth Factor | 2.3 | 52 | Citations (PDF) |
| 560 | Re: Tumor Angiogenesis as a Prognostic Assay for Invasive Ductal Breast Carcinoma | 5.1 | 9 | Citations (PDF) |
| 561 | Enhancement of Tumor Growth and Vascular Density by Transfection of Vascular Endothelial Cell Growth Factor Into MCF-7 Human Breast Carcinoma Cells | 5.1 | 231 | Citations (PDF) |
| 562 | Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis | 5.2 | 366 | Citations (PDF) |
| 563 | An Immunohistochemical and Prognostic Evaluation of Cathepsin D Expression in 105 Bladder Carcinomas | 4.4 | 19 | Citations (PDF) |
| 564 | Potential for protein kinase C inhibitors in cancer therapy | 0.0 | 17 | Citations (PDF) |
| 565 | Expression of xenobiotic-metabolizing enzymes by primary and secondary hepatic tumors in man | 0.7 | 22 | Citations (PDF) |
| 566 | The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233) | 0.7 | 22 | Citations (PDF) |
| 567 | What is the biological, prognostic, and therapeutic role of the EGF receptor in human breast cancer? | 2.5 | 19 | Citations (PDF) |
| 568 | The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients | 2.5 | 131 | Citations (PDF) |
| 569 | Tumor angiogenesis in node-negative breast carcinomas ? relationship with epidermal growth factor receptor, estrogen receptor, and survival | 2.5 | 149 | Citations (PDF) |
| 570 | Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer | 4.4 | 31 | Citations (PDF) |
| 571 | Repair of cisplatin-DNA adducts by protein extracts from human ovarian carcinoma | 4.5 | 24 | Citations (PDF) |
| 572 | bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer | 5.7 | 274 | Citations (PDF) |
| 573 | A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress | 16.2 | 189 | Citations (PDF) |
| 574 | Reversal of P-glycoprotein-mediated multidrug resistance by pure anti-oestrogens and novel tamoxifen derivatives | 5.1 | 42 | Citations (PDF) |
| 575 | Does improved control of tumour growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells? | 3.3 | 26 | Citations (PDF) |
| 576 | Current approaches to targeting cancer using antiangiogenesis therapies | 10.1 | 46 | Citations (PDF) |
| 577 | The role of topoisomerase IIα and β in drug resistance | 10.1 | 38 | Citations (PDF) |
| 578 | Cathepsin D levels in primary breast cancers: Relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status | 3.3 | 14 | Citations (PDF) |
| 579 | Angiogenesis in Breast Cancer. | 4.5 | 17 | Citations (PDF) |
| 580 | bcl-2 Protein in Non-Small-Cell Lung Carcinoma | 25.5 | 588 | Citations (PDF) |
| 581 | Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24 | 16.2 | 218 | Citations (PDF) |
| 582 | Bladder Cancer — Field versus Clonal Origin | 25.5 | 108 | Citations (PDF) |
| 583 | Mechanisms of Multidrug Resistance in Cancer Treatment | 1.9 | 179 | Citations (PDF) |
| 584 | p53, c-erbB-2 and the Epidermal Growth Factor Receptor in the Benign and Malignant Prostate | 4.4 | 155 | Citations (PDF) |
| 585 | p53 Expression in Human Breast Cancer | 3.0 | 32 | Citations (PDF) |
| 586 | Intermittent high-dose tamoxifen as a potential modifier of multidrug resistance | 3.3 | 55 | Citations (PDF) |
| 587 | Reduced topoisomerase II and elevated α class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C | 5.1 | 39 | Citations (PDF) |
| 588 | A study of adhesion molecules as markers of progression in malignant melanoma | 5.2 | 46 | Citations (PDF) |
| 589 | Loss of HLA class-I alleles, heavy chains and β2-microglobulin in colorectal cancer | 4.5 | 56 | Citations (PDF) |
| 590 | Novel growth regulatory factors and tumour angiogenesis | 1.0 | 130 | Citations (PDF) |
| 591 | Isolation and properties in culture of human adrenal capillary endothelial cells | 2.1 | 25 | Citations (PDF) |
| 592 | Interleukin-4 is a potent mitogen for capillary endothelium | 2.1 | 84 | Citations (PDF) |
| 593 | Modulation by verapamil of vincristine pharmacokinetics and sensitivity to metaphase arrest of the normal rat colon in organ culture | 5.1 | 7 | Citations (PDF) |
| 594 | Growth factors and receptors in cancer | 7.6 | 3 | Citations (PDF) |
| 595 | Telling changes of base | 40.1 | 49 | Citations (PDF) |
| 596 | Assessment of renal toxicity by urinary enzymes in patients receiving chemotherapy with 8-methyl-8-acetylenic-putrescine | 2.3 | 0 | Citations (PDF) |
| 597 | Mutant p53—the commonest genetic abnormality in human cancer? | 5.2 | 113 | Citations (PDF) |
| 598 | The epidermal growth factor receptor and the prognosis of bladder cancer | 4.4 | 299 | Citations (PDF) |
| 599 | Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer | 4.4 | 20 | Citations (PDF) |
| 600 | Enhancement of adriamycin® cytotoxicity in a multidrug resistant Chinese hamster ovary (CHO) subline, CHO-Adrr, by toremifene and its modulation by alpha1 acid glycoprotein | 1.0 | 21 | Citations (PDF) |
| 601 | Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure | 2.4 | 127 | Citations (PDF) |
| 602 | The quantitation by radioimmunoassay of 2′-deoxyuridine 5′-triphosphate in extracts of thymidylate synthase-inhibited cells | 2.5 | 12 | Citations (PDF) |
| 603 | Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repair | 2.3 | 7 | Citations (PDF) |
| 604 | Defective repair of DNA single- and double-strand breaks in the bleomycin- and X-ray-sensitive Chinese hamster ovary cell mutant, BLM-2 | 3.7 | 14 | Citations (PDF) |
| 605 | A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesothelioma | 1.0 | 27 | Citations (PDF) |
| 606 | Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer | 1.0 | 13 | Citations (PDF) |
| 607 | Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu | 1.3 | 125 | Citations (PDF) |
| 608 | Modulation of dipyridamole action by α1acid glycoprotein | 5.1 | 16 | Citations (PDF) |
| 609 | Chemotherapy induced emesis may exacerbate the nephrotoxicity of combined ifosfamide/mesna and cisplatin chemotherapy | 1.0 | 2 | Citations (PDF) |
| 610 | Potentiation of quinazoline antifolate (CB3717) toxicity by dipyridamole in human lung carcinoma, A549, cells | 5.1 | 15 | Citations (PDF) |
| 611 | Adenosine-diphosphoribosyltransferase inhibitors can protect against or potentiate the cytotoxicity of S-phase acting drugs | 5.1 | 8 | Citations (PDF) |
| 612 | Bleomycin and X-ray-hypersensitive Chinese hamster ovary cell mutants: Genetic analysis and cross-resistance to neocarzinostatin | 2.1 | 4 | Citations (PDF) |
| 613 | Phase II study of the antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) in advanced breast cancer | 1.0 | 41 | Citations (PDF) |
| 614 | The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16–213, doxorubicin and vincristine (VPAV) for small cell lung cancer | 1.0 | 28 | Citations (PDF) |
| 615 | Plasma prostaglandins in lung cancer | 1.0 | 8 | Citations (PDF) |
| 616 | False-positive ketonuria during ifosfamide and mesna therapy | 1.0 | 6 | Citations (PDF) |
| 617 | To branch or to expand? | 1.6 | 2 | Citations (PDF) |
| 618 | Atf4 | 2.0 | 0 | Citations (PDF) |
